Ipamorelin is a growth hormone secretagogue that has been studied in research settings. This page explains what it is, what the research shows and where it stands with regulators. telos rx does not offer or prescribe ipamorelin, and nothing here is dosing guidance.
Ipamorelin is a growth hormone secretagogue (GHS). It prompts the pituitary gland to release growth hormone in pulses, rather than supplying growth hormone directly. It is known for being selective: in early studies it triggered growth hormone release without meaningfully raising cortisol or prolactin, which set it apart from many other compounds in its class.
Ipamorelin is not FDA-approved for any use. It is not one of the six peptides covered by the interim enforcement discretion policy HHS announced on October 28, 2026 (BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500), and telos rx does not offer it.
How Ipamorelin Works
Ipamorelin binds the ghrelin receptor (also called the growth hormone secretagogue receptor) in the pituitary. That signal releases a pulse of growth hormone, which in turn raises IGF-1, a hormone made mostly by the liver.
The original characterization studies reported its selectivity for growth hormone release over cortisol and prolactin (Raun et al., Eur J Endocrinol 1998). Because insulin and food intake blunt growth hormone release in general, researchers often study secretagogues in a fasted state.
What the Research Has Looked At
Preclinical and early human research has linked ipamorelin to:
- Larger growth hormone pulses
- Higher IGF-1 levels downstream of growth hormone
- Possible effects on lean mass
- Bone markers in animal models
Ipamorelin was also tested in mid-stage clinical trials for postoperative ileus, a slowdown of the bowel after surgery, but it did not go on to reach the market. Long-term human safety data are limited.
What ipamorelin is not: a fat burner, a testosterone booster, or an FDA-approved treatment for any medical condition.
Known Risks and Open Questions
Because ipamorelin raises growth hormone and IGF-1, the concerns researchers raise are the ones tied to the growth hormone axis in general:
- Water retention or joint aches
- Changes in glucose tolerance, which matter most for people with insulin resistance
- Injection site reactions
- Unknown effects of long-term use
Products sold online as "research peptides" are unregulated, so their identity, purity and dose cannot be verified.
Ipamorelin and CJC-1295
Ipamorelin is often discussed alongside CJC-1295, a growth hormone releasing hormone (GHRH) analog. The two act on different points in the growth hormone pathway. Our CJC-1295 and ipamorelin research guide covers how that combination has been studied. Neither peptide is covered by the HHS interim policy.
Regulatory Status
Ipamorelin is not FDA-approved. FDA has listed it among bulk drug substances that may present significant safety risks in compounding, and it is not included in the October 28, 2026 HHS interim enforcement discretion policy, which applies only to six named peptides under strict conditions.
Does telos rx Offer Ipamorelin?
No. telos rx does not offer, prescribe or ship ipamorelin. If growth hormone or recovery is your interest, a licensed healthcare provider can talk through the options that are available to you.
Frequently Asked Questions
What is ipamorelin?
Ipamorelin is a growth hormone secretagogue. It signals the pituitary gland to release growth hormone in pulses and, in early studies, did so without meaningfully raising cortisol or prolactin.
Is ipamorelin FDA-approved?
No. Ipamorelin is not FDA-approved for any indication.
Is ipamorelin covered by the October 2026 HHS peptide policy?
No. The HHS interim enforcement discretion policy announced on October 28, 2026 covers only BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500. Ipamorelin is not included.
Does telos rx offer ipamorelin?
No. telos rx does not offer, prescribe or ship ipamorelin.
Is ipamorelin safe for long-term use?
Long-term human safety data for ipamorelin are limited, and most research comes from preclinical or short human studies. Concerns include water retention, joint aches and changes in glucose tolerance.
This article is for education only and is not medical advice. Ipamorelin is not FDA-approved and is not offered by telos rx.
Want to read more? Browse our Peptide Research blog.